Cervical cancer screening in Mediterranean countries: Implications for the future

Cytopathology

Volumn 21, Issue 6, 2010, Pages 359-367

  Syrjanen K ^a   Di Bonito, L ^b   Goncalves L ^c   Murjal, L ^d   Santamaria, M ^e   Mahovlic, V ^f   Karakitsos, P ^g   Onal B ^h   Schmitt, F C ⁱ  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b MAGGIORE HOSPITAL   (Italy)

^c Hospital do Espirito Santo   (Portugal)

^d The Lisbon and Tagus Valley Health Region Administration   (Portugal)

^e Universidad Pública de Navarra   (Spain)

^f UNIVERSITY OF ZAGREB   (Croatia)

^g NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^h Diskapi Training Research Hospital   (Turkey)

ⁱ University of Porto   (Portugal)

Author keywords

Cervical cancer screening; Cytology; Future strategies; Human error; Human papillomavirus; Mediterranean countries; Organized screening programmes; Prophylactic vaccines; Test performance

Indexed keywords

WART VIRUS VACCINE;

CANCER IMMUNIZATION; CANCER PREVENTION; CANCER SCREENING; CROATIA; CYTOPATHOLOGY; DIAGNOSTIC TEST ACCURACY STUDY; EVALUATION; GREECE; HUMAN; ITALY; PAPANICOLAOU TEST; PORTUGAL; PREDICTIVE VALUE; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; SOUTHERN EUROPE; SPAIN; TURKEY (REPUBLIC); UTERINE CERVIX CANCER; WART VIRUS;

FEMALE; HUMANS; MASS SCREENING; MEDITERRANEAN REGION; UTERINE CERVICAL NEOPLASMS;

EID: 78650438680     PISSN: 09565507     EISSN: 13652303     Source Type: Journal    
DOI: 10.1111/j.1365-2303.2010.00795.x     Document Type: Review

References (27)

1. Gustafsson L, Pontén J, Zack M, Adami H.-O. International incidence rates of cervical cancer after introducing cytological screening. Cancer Causes Control 1997;8:755-63.
2. Anttila A, Pukkala E, Söderman B et al. Effect of organised screening on cervical cancer incidence and mortality in Finland, 1963-1995: recent increase in cervical cancer incidence. Int J Cancer 1999;83:59-65.
3. Peto J, Gilham C, Fletcher O, Matthews FE. The cervical cancer epidemic that screening has prevented in the UK. Lancet 2004;364:249-56.
4. Coleman D, Day N, Douglas G et al. European guidelines for quality assurance in cervical cancer screening. Eur J Cancer 1993;29A(Suppl 4):S1-38.
5. Arbyn M, Anttila A, Jordan J et al. (eds). European guidelines for quality assurance in cervical cancer screening. 2nd edn. Luxembourg: Office of Official Publ EU; 2008. XXXIII.
6. Arbyn M, Autiere P, Ferlay J. Burden of cervical cancer in the 27 member states of the European Union: estimates for 2004. Ann Oncol 2007;18:1425-31.
7. Abstracts of the 34th European Congress of Cytology, Rovaniemi, Finland. Parallel symposium No. 1. Cervical cancer screening in the Baltic countries. Cytopathology 2008;1:32-4.
8. Pinheiro PS, Tyczyński JE, Bray F et al. Cancer incidence and mortality in Portugal. Eur J Cancer 2003;39:2507-20.
9. Goncalves L, Rodrigues C, Marques P et al. Organised cervical cancer screening in Alentejo (Portugal). Abstracts of the 35th European Congress of Cytology, Lisbon, Portugal, Sept. 27-30, 2009. Cytopathology 2009;1:21.
10. Miller AB, Nazeer S, Fonn S et al. Report on consensus conference on cervical cancer screening and management. Int J Cancer 2000;86:440-7.
11. Santamaria M. Cervical screening in Spain. Abstracts of the 35th European Congress of Cytology, Lisbon, Portugal, Sept. 27-30, 2009. Cytopatholology 2009;1:21.
12. Di Bonito L. Cervical screening in Italy. Abstracts of the 35th European Congress of Cytology, Lisbon, Portugal, Sept. 27-30, 2009. Cytopatholology 2009;1:22.
13. Mahovlic V, Pajtler M, Mozetic-Vrdoljak D et al. Cervical screening in Croatia. Abstracts of the 35th European Congress of Cytology, Lisbon, Portugal, Sept. 27-30, 2009. Cytopathology 2009;1:22-3.
14. Karakitsos P. Cervical screening in Greece. Abstracts of the 35th European Congress of Cytology, Lisbon, Portugal, Sept. 27-30, 2009. Cytopathology 2009;1:23.
15. Özgül N. The state of cervical cancer in Turkey and cervical cancer screening studies. In: ELMA. Cancer Control in Turkey, Tuncer M (ed.), Ankara: Ministry Publication no:740, ISBN 978-975-590-256-2, 2008: pp. 347-57.
16. Önal B. Turkey's cytology efforts concerning cancer screening & cytoscreeners' training programs. A review and a consensus report declared by Turkish society of Cytopathology under auspices of Turkish Federation of Pathology Societies. Abstracts of the 35th European Congress of Cytology, Lisbon, Portugal, Sept. 27-30, 2009. Cytopathology 2009;1:23-4.
17. Ayhan A, on behalf of Turkish Cervical and Cancer Cervical Cytology Research Group. Prevalence of cervical cytological abnormalities in Turkey. Int J Gynecol Obstet 2009;106:206-9.
18. Önal B, Tuzlali S. Who is the cytology screener?: the implementation of cytotechnicians & cytotechnologists within the national health system and their training programs. (oral presentation), In: 1st National Congress of Colposcopy & Cervical Pathologies, Yüce K (ed.) Antalya: Congress Book; 2008: pp. 22.
19. Franco EL, Cuzick J. Cervical cancer screening following prophylactic human papillomavirus vaccination. Vaccine 2008;26S:A16-23.
20. Wheeler CM, Franceschi S. EUROGIN 2007 road map - conclusion. Vaccine 2008;26S:A28-31.
21. Harper DM, Franco EL, Wheeler CM et al. Sustained efficacy up to 4.5 years or a bivalent L1 virus-like particle vaccine against human papillomavirus type 16 and 18: follow-up from a randomised control trial. Lancet 2006;367:1247-55.
22. Villa LL, Costa RL, Petta CA et al. High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up. Br J Cancer 2006;95:1459-66.
23. Cuzick J, Clavel C, Petry KU et al. Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Cancer 2006;119:1095-105.
24. Syrjänen K, Naud P, Derchain SF et al. Value of conventional Pap smear, Liquid Based Cytology, visual inspection (VIA) and Human papillomavirus (HPV) testing as optional screening tools among Latin American women < 35 and > 35 years of age. Experience from the LAMS Study. Acta Cytol 2008;52:641-53.
25. Sigurdsson K, Sigvaldason H. Effectiveness of cervical cancer screening in Iceland, 1964-2002: a study on trends in incidence and mortality and the effect of risk factors. Acta Obstet Gynecol Scand 2006;85:343-9.
26. Lynge E, Antilla A, Arbyn M, Segnan N, Ronco G. What's next? Perspectives and future needs of cervical screening in Europe in the era of molecular testing and vaccination. Eur J Cancer 2009;45:2714-21.
27. Arbyn M, Raifu AO, Weiderpass E, Bray F, Anttila A. Trends of cervical cancer mortality in the member states of the European Union. Eur J Cancer 2009;45:2640-8.